Federated Hermes’s Olema Pharmaceuticals OLMA Stock Holding History

Federated Hermes’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$967K	Buy	77,266 +63,180	+449%	+$846K	﹤0.01%	1167
2026 Q1	$210K	Buy	+14,086	New	+$314K	﹤0.01%	1483
2025 Q1	–	Sell	-150	Closed	-$875	–	2158
2024 Q4	$875	Buy	+150	New	+$1.5K	﹤0.01%	2025
2023 Q4	–	Sell	-1,035	Closed	-$12.8K	–	2160
2023 Q3	$12.8K	Sell	1,035 -297	-22%	-$3.03K	﹤0.01%	1802
2023 Q2	$12K	Sell	1,332 -377	-22%	-$2.28K	﹤0.01%	1831
2023 Q1	$5.93K	Sell	1,709 -1,865	-52%	-$7.61K	﹤0.01%	1917
2022 Q4	$8.76K	Buy	3,574 +673	+23%	+$1.96K	﹤0.01%	1881
2022 Q3	$8K	Sell	2,901 -1,664	-36%	-$7.06K	﹤0.01%	1855
2022 Q2	$19K	Buy	4,565 +2,105	+86%	+$6.68K	﹤0.01%	1775
2022 Q1	$10K	Buy	2,460 +2,355	+2,243%	+$13K	﹤0.01%	1887
2021 Q4	$1K	Sell	105 -259,895	-100%	-$5.38M	﹤0.01%	2133
2021 Q3	$7.17M	Hold	260,000	–	–	0.01%	738
2021 Q2	$7.28M	Hold	260,000	–	–	0.01%	744
2021 Q1	$8.63M	Hold	260,000	–	–	0.02%	710
2020 Q4	$12.5M	Buy	+260,000	New	+$12.2M	0.03%	584

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Federated Hermes's OLMA Position: Q2 2026 in Review

Federated Hermes increased its Olema Pharmaceuticals (OLMA) stake by 449% in Q2 2026, buying an estimated $846K and bringing the position to 77,266 shares worth $967K. The position accounts for ﹤0.01% of the portfolio, ranked #1167.

Federated Hermes first reported a position in OLMA in Q4 2020 and has held it in 15 quarters since. The position peaked at $12.5M in Q4 2020. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

Federated Hermes held 77,266 shares of Olema Pharmaceuticals worth $967K as of Q2 2026.
Federated Hermes bought 63,180 Olema Pharmaceuticals shares in Q2 2026, an estimated $846K.
Olema Pharmaceuticals made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1167 holding.
Federated Hermes first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 15 quarters since.
Federated Hermes's Olema Pharmaceuticals position peaked at $12.5M in Q4 2020.
185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.